140D0421F0590↗

Essex Management LLC received this contract from Ibc Acq Svcs Directorate (00004), Departmental Offices: $12.25M obligated so far for it and telecom - business application/application development support services (labor). Its period of performance ended 2026-08-31.

Key facts · data as of Oct 25, 2026

Recipient
Essex Management LLC
Awarding agency
Departmental Offices (Department of the Interior)
Contracting office
Ibc Acq Svcs Directorate (00004) (140D04)
Obligated to date
$12.25M
Potential value
$20.65M
Ends
2026-08-31

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award 140D0421F0590, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_140D0421F0590_1406_140D0421D0007_1406

CLINICAL TRIALS REPORTING OFFICE (CTRO)

Delivery Order · Departmental Offices · to Essex Management LLC (UEI W43LZWHV2853) · data as of 2026-10-25

Obligated to date$12.25M12 actions
Current value$20.65Mwith options exercised
Period2021-09-01 → 2026-08-31current end date

Up for re-bid: ends 2026-08-31. Recompete brief →

What it is

Product or service
IT and Telecom - Business Application/Application Development Support Services (Labor) (PSC DA01)
Industry
Other Scientific and Technical Consulting Services (NAICS 541690)
Funded by
Department of Health and Human Services
Contracting office
Ibc Acq Svcs Directorate (00004) (140D04)
Competition
Full and open competition · 7 offers received
Pricing
Time and materials
How it was bought
Multiple-award IDIQ · under 140D0421D0007
Solicitation
140D0421R0007
Where the work is
Montgomery, MD · district MD-08

Obligations by fiscal year

FY2023$4.13M
FY2024$4.38M
FY2025$3.74M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

12 actions since 2022-12-09. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2025-09-24P00015Supplemental agreement (work within scope)-$195CLINICAL TRIALS REPORTING OFFICE (CTRO)
2025-08-27P00014Option exercised$3.85MCLINICAL TRIALS REPORTING OFFICE (CTRO)
2025-08-22P00013Supplemental agreement (work within scope)$0CLINICAL TRIALS REPORTING OFFICE (CTRO)
2025-04-03P00012Terminated for convenience$0CLINICAL TRIALS REPORTING OFFICE (CTRO)
2024-12-02P00011Supplemental agreement (work within scope)-$108.3KCLINICAL TRIALS REPORTING OFFICE (CTRO)
2024-08-02P00010Option exercised$4.38MCLINICAL TRIALS REPORTING OFFICE (CTRO)
2023-11-09P00009Administrative change$0CLINICAL TRIALS REPORTING OFFICE (CTRO)
2023-09-20P00008Supplemental agreement (work within scope)-$17.9KCLINICAL TRIALS REPORTING OFFICE (CTRO)
2023-09-19P00007Administrative change$0CLINICAL TRIALS REPORTING OFFICE (CTRO)
2023-08-16P00006Option exercised$4.49MCLINICAL TRIALS REPORTING OFFICE (CTRO)
2022-12-15P00005Funding only$3CLINICAL TRIALS REPORTING OFFICE (CTRO)
2022-12-09P00004Supplemental agreement (work within scope)-$342.1KCLINICAL TRIALS REPORTING OFFICE (CTRO)

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗